Now we require the MND Biomarkers and Pharmacodynamic data?
Does anyone have any idea at all when this will be completed?
By my reckoning Cohort 1 and 2 gave bloods and urine samples on the set days required , so I'm confused and disappointed why this information is not present today..
The MND Biomarkers are integral to define if MPL is having a positive effect on the actual Disease...NZT
I'm elated that we have a quality safety profile but TBH we knew this as the trial was still progressing and had not struck a single red flag from the DSMB..
Ann: PharmAust MND Trial Interim Analysis PK Outcomes, page-13
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $111.9M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $289.4K | 1.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 149248 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 6664 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |